Chongqing, China

Mei Liu

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Chongqing Upgra Biotechnology Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei Liu. Retrieved from https://idiyas.com/inventor/mei-liu-km497kwx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 27.4

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mei Liu - Innovator in Polyethylene Glycol Conjugate Drugs

Introduction

Mei Liu is a prominent inventor based in Chongqing, China. She has made significant contributions to the field of medicine, particularly in the development of polyethylene glycol conjugate drugs. With a total of two patents to her name, her work is paving the way for advancements in pharmaceutical compositions.

Latest Patents

Mei Liu's latest patents include a polyethylene glycol conjugate drug and a preparation method therefor and use thereof. This invention relates to the technical field of medicines and focuses on a polyethylene glycol conjugated drug, as well as a method for preparing this drug and its pharmaceutically acceptable salts. The second patent, titled polyethylene glycol conjugate medicament, also emphasizes the preparation method and its applications in drug formulation.

Career Highlights

Mei Liu is currently associated with Chongqing Upgra Biotechnology Co., Ltd. Her work at this company highlights her commitment to advancing medical technology and improving drug delivery systems.

Collaborations

Some of her notable coworkers include Gaoquan Li and Dajun Li, who contribute to the innovative environment at Chongqing Upgra Biotechnology Co., Ltd.

Conclusion

Mei Liu's contributions to the field of polyethylene glycol conjugate drugs demonstrate her dedication to medical innovation. Her patents reflect her expertise and commitment to improving pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…